• 1
    Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993; 328: 24652
  • 2
    Gerber GS, Bales G, Kirsh E, Christiano AP. Medicinal botanicals in the treatment of lower urinary tract symptoms (LUTS): a demographic analysis of awareness and use at the University of Chicago. J Urol 1998; 159: 334, A1282
  • 3
    Lowe FC, Ku JC. Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology 1996; 48: 12
  • 4
    Lowe FC, Fagelman E. Phytotherapy in treatment of BPH. An update. Urology 1999; 53: 6718
  • 5
    Dreikon K. Other medical therapies. In DenisL, GriffithsK, MurphyG eds, Proceedings of the Fourth International Consultation on Benign Prostatic Hyperplasia (BPH), Paris July 2–5 1997. Plymouth, UK: Health Publication Ltd, 1998: 6359
  • 6
    Buck AC. Phytotherapy for the prostate. Br J Urol 1996; 78: 32536
  • 7
    Lowe FC, Roerhrborn CG, Robertson C, Boyle P. Meta-analysis of clinical trials of Permixon. J Urol 1998; 159: 257, A986
  • 8
    Lowe FC, Dreikorn K, Borkowski A, Braeckman J et al. Review of recent placebo controlled trials utilising phytotherapeutic agents for treatment of BPH. Prostate 1998; 37: 18793
  • 9
    Breza J, Dzurny O, Borowka J et al. Efficacy and acceptability of Tadenan in the treatment of BPH. A multiculture trial in Central Europe. Current Med Res Opinion 1998; 14: 12739
  • 10
    Berges RR, Windeler J, Trampisch H, Senge TH. Beta sitosterol in patients with benign prostatic hyperplasia. Lancet 1995; 345: 152932
  • 11
    Senge T, Windeler J, Berges RR et al. Wirksamkeit von B-sitosterin bei der behandlung von BPH. Urologe (a) 1995; 34: 1301
  • 12
    Carro J, Raynaud JP, Koch G et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of BPH. A randomised international study of 1089 patients. Prostate 1996; 29: 23140
  • 13
    Geller J, Sionit L, Partido C et al. Genistein inhibits the growth of human patient BPH and prostate cancer in histoculture. Prostate 1998; 34: 759